All News

The deadline for eligible hospitals and critical access hospitals to attest to meeting meaningful use requirements has been pushed back a full month, according to CMS.

Genentech's decision to use a handful of specialty drug distributors instead of wholesalers for the distribution of the most commonly used anticancer medications has raised concerns of availability and cost.

The large retrospective study, conducted in 9.8 million men, identified a strong association between obesity and the development of an advanced and more aggressive form of the disease.

In the first 2 years of the Affordable Care Act, open enrollment has run for 2 different time periods, and HHS is looking to set a fixed date for future years. Plus, it offers a solution to automatic re-enrollment.

The monoclonal antibody,a c-Met inhibitor, was being tested in advanced gastric cancer patients following it's revival 2 years back.

The disclosure that a calculation error caused the Obama administration to add an extra 400,000 people to ACA enrollment figures for months puts a dent in the 2015 open enrollment, in part because it fits a narrative of a lack of transparency for reporters who cover the administration.

In the update, the FDA is now asking the device manufacturers to include a black box warning and contraindications, to warn both providers and patients of possible health risks with the procedure.

This article in The New York Times details the reasons why private oncology practices are being forced to consolidate to stay afloat.

Laws allowing terminal patients to try drugs not approved by the FDA have passed in five states, but experts question their efficacy.

The study, published in Nature Medicine, identified a small molecule inhibitor that increases histone methylation, compensating for the reduced methylation caused by mutation in the H3F3A gene, resulting in gliomas.

The leaders of the United Nations and the World Health Organization expressed renewed alarm on Friday about Ebola's tenacity in Africa and, in particular, its potential to ravage a fourth country, Mali, where they said hundreds of people had been exposed to an infected cleric who died last month.

Researchers at Vanderbilt University Medical Center have used electronic health record analysis to uncover hidden drug benefits, according to a study appearing in the Journal of the American Medical Informatics Association.

A HIPAA-compliant app developed by doctors at the Arnold Palmer Hospital for Children in Orlando, helps quell the anxiety of family members as their children undergo surgery.

Champions Oncology will be presenting data on it's preclinical model at the ongoing EORTC-NCI-AACR Symposium in Barcelona. The model proposes to help develop individualized treatments for patients.

In March, the Obama administration released guidance extending the renewal of health insurance policies that do not meet the Affordable Care Act's coverage standards through October 1, 2016. At least 9 states that did not adopt the administration's original transitional policy are now allowing renewals of noncompliant policies after January 1, 2014.

Randomized trials are highly effective for suggesting ways to improve healthcare delivery, but they're also rare. That may be changing.

Republicans finally filed a lawsuit against President Obama's healthcare reform law, the Affordable Care Act, after approving the suit in July. They are challenging the employer-based coverage aspect of the law, as well as Treasury payments to insurers.

Scientists at the Memorial Sloan Kettering Cancer Center have identified that tumor mutation burden could help predict responders to ipilimumab treatment. The report has been published online in the New England Journal of Medicine.

A recent study published in European Urology highlights quality-of-life benefits with active surveillance in men with prostate cancer.

Vermont Senator Bernie Sanders has introduced a bill that would require generic drugmakers to pay rebates to the federal Medicare and Medicaid programs when prices of their medications outpace inflation.

The study, published in Cell Reports, evaluates the dynamic protein interactions that promote different diseases including cancer. By capturing these interactions, the authors hope to discover new drug targets.

A new study shows only a small share of patients with private insurance who were newly diagnosed with diabetes in 2011-2012 enrolled in self-management training, raising questions about how well managed care could address both long-term health and cost control for this important group. These patients are a target for special attention under the ACA.

Being promised a 100% reimbursement, Gilead will now make the drug available to HCV patients in France at 60% of the cost in the United States.

The retrospective study, published in JAMA Surgery, could not necessarily point to the underlying reason for this treatment choice.

According to the report, sofosbuvir for hepatitis C infections and new cancer drugs were the drivers of the high spending costs, a 7% jump over the previous year.

Clinicians are showing increased openness toward using digital technology and are becoming more comfortable with trusting tools like at-home test results, according to a new report from PwC's Health Research Institute.

An examination of nearly 200 medication adherence trials found that it is actually difficult to determine whether or not the approaches truly worked.

Employee wellness programs are now being supported by apps developed by technology giants like Google and Apple. But are they really helping keep patients engaged and on-track with their health goals?

With an aim to create parity between brand-name and generic drugs, the FDA was expected to pass a rule next month that would allow generic manufacturers to independently provide safety updates on their labels. The decision has now been pushed back by 9 months.

In an effort to foster greater transparency of healthcare costs, the government and private sector entities are offering tools that provide cost and quality information to consumers. But just how effective are these tools?